Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica.

Fiche publication

Date publication

août 2024

Journal

RMD open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNOTTE Bernard , Pr ORNETTI Paul

Tous les auteurs :
Ramon A, Greigert H, Goueslard K, Cladière C, Ciudad M, Ornetti P, Audia S, Maillefert JF, Bonnotte B, Samson M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39122253

Résumé

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be used to identify GCA in cases of apparently isolated PMR.